InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-43.1%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Luci David P, 首席执行官. Director active across 1 company, notably Acurx Pharmaceuticals, Inc.. In total, 4 reports have been recorded. Split: 3 buys · 0 sell. Total volume traded: €144k. Activity tracked since 19 November 2021. The latest transaction was disclosed on 6 January 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Luci David P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
49,261 股@ US$1.01521.1% 占其流量Common StockSEC:0001104659-25-002052:0
标准退出：2025年4月6日 (T+90)
19,737 股@ US$3.5527.9% 占其流量Common StockSEC:0001104659-24-001373:0
19,737 股@ US$3.8032.0% 占其流量Common StockSEC:0001104659-22-084315:0
标准退出：2022年10月25日 (T+90)
5,200 股@ US$4.8010.6% 占其流量Common StockSEC:0001104659-21-142471:0
标准退出：2022年2月17日 (T+90)
4 条申报中的 4 条
About Luci David P
David P. Luci is President and CEO of Acurx Pharmaceuticals, Inc. He leads the company in its efforts to research and develop new drugs. His leadership is crucial for Acurx's strategy and growth.
